Story Navigation
-
People and CultureDrug DiscoveryNeurodegenerative DiseaseNeuroscienceNovartis Institutes for BioMedical ResearchScientific Research
In neuroscience, “an inflection point in knowledge and technology”
People and Culture -
Patient PerspectivesCancerOncologyPatient Voices
Let’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero
Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.
Patient Perspectives -
Access to HealthcareAccess to HealthcareClinical ResearchDrug DevelopmentInfectious DiseasesTropical Diseases
Renewing our commitment to neglected tropical disease and malaria elimination
Thierry Diagana and Jonathan Spector from the Novartis Institute for Tropical Diseases (NITD) discuss learnings about their work in Neglected Tropical Diseases (NTDs) and share insights into the factors, which could lead to a resurgence of these diseases.
Access to Healthcare -
Access to HealthcareAccess to HealthcareAfricaChildren's HealthNovartis Access
Sickle cell screening urged for newborns in Africa
Sickle cell disease disproportionately affects babies in Africa, but many go undiagnosed due to lack of screening. Newborn screening is needed to save lives and improve care.
Access to Healthcare -
DiscoveryCancerDrug DiscoveryNovartis Institutes for BioMedical ResearchOncologyWomen in Science
A shared mission to take on the “impossible” in cancer research
Discovery -
Access to HealthcareAccess to HealthcareCancerOncologySocial CommitmentTargeted Therapy
Prostate Cancer: A collective commitment to serving underserved communities
Raising awareness of the ways in which prostate cancer can affect the sexual minority and gender minority communities.
Access to Healthcare -
DiscoveryCancerCell and Gene TherapyChildren's HealthNovartis Institutes for BioMedical ResearchOncology
How Emily’s act of bravery inspired a wave of continued innovation
Inspired by Emily Whitehead, along with other early patients treated with CAR-T cell therapy, Novartis embarked on a pioneering journey to reimagine cancer treatment. After 10 years, we continue to relentlessly pursue new science around cell and gene therapies to transform the lives of patients today and in the future.
Discovery -
Access to HealthcareAccess to HealthcareCancerNovartis AccessSocial Commitment
Boosting access to cancer care where it’s needed most
Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.
Access to Healthcare -
Access to HealthcareAccess to HealthcareInfectious DiseasesMalariaMedical InnovationsTropical Diseases
Staying one step ahead of the malaria parasite
Thierry Diagana and his team are on a quest to discover new therapeutics for malaria. He believes malaria elimination is within our grasp, but emerging drug resistance could jeopardize the hard-fought progress.
Access to Healthcare -
Access to HealthcareChronic IllnessEnvironmental SustainabilityInfectious DiseasesMalariaNovartis Institutes for BioMedical Research
Tackling the health toll of climate change
Access to Healthcare -
Patient Perspectives
Understanding hidradenitis suppurativa through Jasmine’s eyes
Patient Perspectives -
Access to HealthcareAccess to HealthcareCardiovascular DiseaseHeart DiseaseNovartis Access
Prioritizing the needs of patients
Access to Healthcare
Pagination
- ‹ Previous page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- …
- 33
- › Next page